DE69820265D1 - Für den vogelembryo geeignete multivalente impfstoffe - Google Patents

Für den vogelembryo geeignete multivalente impfstoffe

Info

Publication number
DE69820265D1
DE69820265D1 DE69820265T DE69820265T DE69820265D1 DE 69820265 D1 DE69820265 D1 DE 69820265D1 DE 69820265 T DE69820265 T DE 69820265T DE 69820265 T DE69820265 T DE 69820265T DE 69820265 D1 DE69820265 D1 DE 69820265D1
Authority
DE
Germany
Prior art keywords
multivalent vaccine
multivalent
poultry
vaccine suitable
bird embryo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69820265T
Other languages
English (en)
Inventor
M Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Application granted granted Critical
Publication of DE69820265D1 publication Critical patent/DE69820265D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69820265T 1997-06-12 1998-06-04 Für den vogelembryo geeignete multivalente impfstoffe Expired - Lifetime DE69820265D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,103 US6048535A (en) 1997-06-12 1997-06-12 Multivalent in ovo avian vaccine
PCT/US1998/011470 WO1998056413A1 (en) 1997-06-12 1998-06-04 Multivalent in ovo avian vaccine

Publications (1)

Publication Number Publication Date
DE69820265D1 true DE69820265D1 (de) 2004-01-15

Family

ID=25362980

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820265T Expired - Lifetime DE69820265D1 (de) 1997-06-12 1998-06-04 Für den vogelembryo geeignete multivalente impfstoffe

Country Status (9)

Country Link
US (2) US6048535A (de)
EP (1) EP0996464B1 (de)
JP (1) JP2002504117A (de)
CN (1) CN1132628C (de)
AT (1) ATE255419T1 (de)
AU (1) AU7814498A (de)
CA (1) CA2301196A1 (de)
DE (1) DE69820265D1 (de)
WO (1) WO1998056413A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
DK0831897T3 (da) * 1995-06-07 2001-04-30 Pfizer In ovo-vaccination mod coccidiosis
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US20070269456A1 (en) * 2001-11-05 2007-11-22 Lasher Alfred W DNA-based plasmid formulations and vaccines and prophylactics containing the same
US20030228327A1 (en) * 2001-11-05 2003-12-11 Lasher Alfred W. DNA-based plasmid formulations and vaccines and prophylactics containing the same
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
US7037506B2 (en) * 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
AU2003298578A1 (en) * 2002-09-16 2004-04-23 Wyeth Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
ES2422885T3 (es) 2003-12-03 2013-09-16 Zoetis P Llc Vacunación in ovo de campylobacter en especies aviares
US20060196428A1 (en) * 2005-03-03 2006-09-07 Correa Rafael S Method for improving chick hatchability
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
CN101460192A (zh) * 2006-03-30 2009-06-17 恩布里克斯公司 家禽疫苗接种的方法和组合物
WO2008076518A2 (en) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine
WO2010130374A1 (en) 2009-05-14 2010-11-18 Bayer Animal Health Gmbh Enhanced immune response in avian species
US8524249B2 (en) 2009-12-15 2013-09-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
BR112013002525A2 (pt) * 2010-08-02 2016-05-31 Univ Georgia vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo
EP2654785B1 (de) 2010-12-22 2019-03-20 Bayer Intellectual Property GmbH Erhöhte immunreaktion bei rindergattungen
RU2593950C2 (ru) 2011-10-21 2016-08-10 Интервет Интернэшнл Б.В. Рекомбинантный непатогенный mdv-вектор, обеспечивающий полиспецифический иммунитет
US8932604B2 (en) 2011-10-21 2015-01-13 Intervet Inc. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
WO2014077096A1 (ja) * 2012-11-15 2014-05-22 一般財団法人化学及血清療法研究所 ベクターワクチンおよび生ワクチンの併用による感染症の予防方法
MX2016010993A (es) 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
AU2017274332B2 (en) 2016-06-02 2024-06-27 Zoetis Services Llc Vaccine against infectious bronchitis
WO2019010135A1 (en) 2017-07-05 2019-01-10 Arizona Board Of Regents On Behalf Of Arizona State University VACCINE AGAINST NECROTIC ENERTITIES IN POULTRY
US11464849B2 (en) 2019-09-11 2022-10-11 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040388A (en) * 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4882148A (en) 1987-06-18 1989-11-21 Corvita Corporation Crack prevention and improved thrombogenicity of implanted prostheses by sulfonation
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
MX9700170A (es) * 1994-06-20 1997-04-30 Los Estados Unidos De America Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
US5733556A (en) * 1995-10-18 1998-03-31 Akzo Nobel N.V. Newcastle disease virus combination vaccine
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine

Also Published As

Publication number Publication date
EP0996464B1 (de) 2003-12-03
US6406702B1 (en) 2002-06-18
CN1132628C (zh) 2003-12-31
CN1261283A (zh) 2000-07-26
CA2301196A1 (en) 1998-12-17
WO1998056413A1 (en) 1998-12-17
ATE255419T1 (de) 2003-12-15
JP2002504117A (ja) 2002-02-05
EP0996464A1 (de) 2000-05-03
US6048535A (en) 2000-04-11
AU7814498A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
DE69820265D1 (de) Für den vogelembryo geeignete multivalente impfstoffe
ATE411043T1 (de) Verfahren von dna-impfung
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
DK0912194T3 (da) Polynucleotid-vaccineformulering, især til behandling af respiratorisk sygdom hos kvæg
BRPI0509104A (pt) métodos e aparelho para injeção por jato automática de ovos de aves
PT714444E (pt) Atenuacao de um epitopo imunodominante de um antigenio para utilizacao em vacinas e imunoterapias para plantas, animais e homens
ATE166530T1 (de) Vorrichtung zur frühembryonalen in ovo injektion
UA41381C2 (uk) Спосіб вакцинації птиці in ovo проти кокцидіозу
LV11719A (lv) Sastavs dzivnieku kautkermenu saglabasanas uzlabosanai
BR0306941A (pt) Método para identificar se um ovo contém um embrião vivo, e, método e aparelho para produzir uma vacina dentro de uma pluralidade de ovos
PT1024189E (pt) Nova classe antigenica de reovirus avicolas
NO975360L (no) Peptid som inhiberer forhöyede triglyseridnivåer i blod og midler som inneholder nevnte peptid som aktiv komponent
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
BR0213043A (pt) Métodos de tratar ou prevenir dusfunção contrátil miocárdica após infarto do miocárdio em um sujeito, de tratar ou prevenir cardiomiopatia dilatada em um sujeito e de incrementar contratilidade miocárdica em um sujeito, animal transgênico, e, método de identificar um composto que pode tratar doença estrutural do coração
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
HUP0402098A2 (hu) Baromfibetegségeket okozó új baktérium és ebből származó vakcina
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
MX9700170A (es) Inmunizacion in ovo de embriones de aves con vacunas de emulsion en aceite.
BR9812066A (pt) Processo para tratamento ou prevenção de infecção entérica ou respiratória bacteriana em um animal de criação
Sharma Multivalent in ovo avian vaccine
NO20025898L (no) Fremgangsmater og tilhorende preparater for a oke overlevelsen av akvatiske dyr og andre dyr som utsettes for et akvatisk virus, birnavirus eller annet RNAvirus
SE7704856L (sv) Medel for oral tillforsel pa husdjur utan cellulosasmeltning i vam
PT819378E (pt) Alojamento de transponder implantavel, para animais de criacao
AR007611A1 (es) Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek
ES1042341Y (es) Canula para inseminacion artificial de ganado porcino.

Legal Events

Date Code Title Description
8332 No legal effect for de